Latest News and Press Releases
Want to stay updated on the latest news?
-
The FDA has accepted Lykos Therapeutics' New Drug Application, supported by two decades of research incubated by MAPS, for MDMA-assisted therapy for PTSD.
-
MAPS shares ownership of Lykos with mission-aligned investors, will continue to advance psychedelic research, change drug policy, and shape culture
-
The first NDA submission for any psychedelic-assisted therapy has been submitted through a 30-year effort initiated and led by the nonprofit MAPS
-
NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
-
LOS ANGELES, May 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
-
SAN FRANCISCO, June 25, 2020 (GLOBE NEWSWIRE) -- (June 25, 2020) – via NetworkWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies...